David Hamilton at Venture Beat covers the latest events at CIRM, the California Institute for Regenerative Medicine. While the $3 billion stem cell program has started disbursing funds to scientists, bad news continues to hound the endeavor. Most recently, Arlene Chiu, the interim chief scientific officer, resigned unexpectedly, Hamilton writes. Her departure follows on the heels of the resignation earlier this year of Zach Hall, CIRM's first president.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.